These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Structure-based design of peptides that recognize the CD4 binding domain of HIV-1 gp120. Fontenot JD; Tan X; Phillips DM AIDS; 1998 Aug; 12(12):1413-8. PubMed ID: 9727561 [TBL] [Abstract][Full Text] [Related]
23. CD4-imitating human antibodies in HIV infection and anti-idiotypic vaccination. Deckert PM; Ballmaier M; Lang S; Deicher H; Schedel I J Immunol; 1996 Jan; 156(2):826-33. PubMed ID: 8543839 [TBL] [Abstract][Full Text] [Related]
24. Insights into the interaction of CD4 with anti-CD4 antibodies. Bui VC; Nguyen TH Immunobiology; 2017 Feb; 222(2):148-154. PubMed ID: 27773661 [TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibodies raised against covalently crosslinked complexes of human immunodeficiency virus type 1 gp120 and CD4 receptor identify a novel complex-dependent epitope on gp 120. DeVico AL; Rahman R; Welch J; Crowley R; Lusso P; Sarngadharan MG; Pal R Virology; 1995 Aug; 211(2):583-8. PubMed ID: 7544051 [TBL] [Abstract][Full Text] [Related]
26. Binding to CD4 of synthetic peptides patterned on the principal neutralizing domain of the HIV-1 envelope protein. Autiero M; Abrescia P; Dettin M; Di Bello C; Guardiola J Virology; 1991 Dec; 185(2):820-8. PubMed ID: 1720590 [TBL] [Abstract][Full Text] [Related]
27. Oligomerization of CD4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp120. Sakihama T; Smolyar A; Reinherz EL Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6444-8. PubMed ID: 7604010 [TBL] [Abstract][Full Text] [Related]
28. Generation and characterization of a human monoclonal antibody that neutralizes diverse HIV-1 isolates in vitro. Lake DF; Kawamura T; Tomiyama T; Robinson WE; Matsumoto Y; Masuho Y; Hersh EM AIDS; 1992 Jan; 6(1):17-24. PubMed ID: 1543562 [TBL] [Abstract][Full Text] [Related]
29. Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120. Dianzani U; Bragardo M; Buonfiglio D; Redoglia V; Funaro A; Portoles P; Rojo J; Malavasi F; Pileri A Eur J Immunol; 1995 May; 25(5):1306-11. PubMed ID: 7539755 [TBL] [Abstract][Full Text] [Related]
30. Brain-derived cells contain a specific binding site for Gp120 which is not the CD4 antigen. Kozlowski MR; Sandler P; Lin PF; Watson A Brain Res; 1991 Jul; 553(2):300-4. PubMed ID: 1933287 [TBL] [Abstract][Full Text] [Related]
31. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds. Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646 [TBL] [Abstract][Full Text] [Related]
32. CD4-derived synthetic peptide blocks the binding of HIV-1 GP120 to CD4-bearing cells and prevents HIV-1 infection. Shapira-Nahor O; Golding H; Vujcic LK; Resto-Ruiz S; Fields RL; Robey FA Cell Immunol; 1990 Jun; 128(1):101-17. PubMed ID: 1971526 [TBL] [Abstract][Full Text] [Related]
33. Sulfated polyanions prevent HIV infection of lymphocytes by disruption of the CD4-gp120 interaction, but do not inhibit monocyte infection. Lynch G; Low L; Li S; Sloane A; Adams S; Parish C; Kemp B; Cunningham AL J Leukoc Biol; 1994 Sep; 56(3):266-72. PubMed ID: 7521897 [TBL] [Abstract][Full Text] [Related]
34. Structure of Simian Immunodeficiency Virus Envelope Spikes Bound with CD4 and Monoclonal Antibody 36D5. Hu G; Liu J; Roux KH; Taylor KA J Virol; 2017 Aug; 91(16):. PubMed ID: 28539445 [TBL] [Abstract][Full Text] [Related]
35. Mutational analysis of the interaction between CD4 and class II MHC: class II antigens contact CD4 on a surface opposite the gp120-binding site. Fleury S; Lamarre D; Meloche S; Ryu SE; Cantin C; Hendrickson WA; Sekaly RP Cell; 1991 Sep; 66(5):1037-49. PubMed ID: 1889086 [TBL] [Abstract][Full Text] [Related]
36. Interaction of seminal plasma proteins with cell surface antigens: presence of a CD4-binding glycoprotein in human seminal plasma. Autiero M; Abrescia P; Guardiola J Exp Cell Res; 1991 Dec; 197(2):268-71. PubMed ID: 1959561 [TBL] [Abstract][Full Text] [Related]
37. Mouse CD4 binds MHC class II with extremely low affinity. Weber S; Karjalainen K Int Immunol; 1993 Jun; 5(6):695-8. PubMed ID: 8347561 [TBL] [Abstract][Full Text] [Related]
38. Amino acid residues of the human immunodeficiency virus type I gp120 critical for the binding of rat and human neutralizing antibodies that block the gp120-sCD4 interaction. McKeating JA; Thali M; Furman C; Karwowska S; Gorny MK; Cordell J; Zolla-Pazner S; Sodroski J; Weiss RA Virology; 1992 Sep; 190(1):134-42. PubMed ID: 1382339 [TBL] [Abstract][Full Text] [Related]
39. V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies. Ly A; Stamatatos L J Virol; 2000 Aug; 74(15):6769-76. PubMed ID: 10888615 [TBL] [Abstract][Full Text] [Related]